ProShare Advisors’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-8,122
Closed -$285K 2240
2021
Q4
$285K Sell
8,122
-3,442
-30% -$112K ﹤0.01% 1818
2021
Q3
$423K Buy
11,564
+1,871
+19% +$73.6K ﹤0.01% 1307
2021
Q2
$381K Buy
9,693
+2,504
+35% +$72.3K ﹤0.01% 1729
2021
Q1
$203K Sell
7,189
-758
-10% -$24.2K ﹤0.01% 2034
2020
Q4
$254K Buy
7,947
+35
+0.4% +$1.08K ﹤0.01% 1720
2020
Q3
$256K Buy
7,912
+111
+1% +$3.46K ﹤0.01% 1285
2020
Q2
$215K Buy
+7,801
New +$169K ﹤0.01% 1415
2020
Q1
Sell
-9,010
Closed -$226K 1344
2019
Q4
$226K Buy
+9,010
New +$197K ﹤0.01% 1514
2019
Q3
Sell
-10,447
Closed -$230K 1672
2019
Q2
$230K Sell
10,447
-1,054
-9% -$30.1K ﹤0.01% 1361
2019
Q1
$352K Buy
11,501
+1,190
+12% +$29.7K ﹤0.01% 1181
2018
Q4
$238K Buy
+10,311
New +$320K ﹤0.01% 1278

Other funds holding HCM

ProShare Advisors's HCM Position: Q1 2022 in Review

ProShare Advisors sold out of HUTCHMED (HCM) in Q1 2022, closing a stake of 8,122 shares — an estimated $285K sold.

ProShare Advisors first reported a position in HCM in Q4 2018 and held it in 11 quarters. The position peaked at $423K in Q3 2021. 130 funds tracked by Wall St. Rank hold HCM as of Q1 2022.

  • ProShare Advisors reported no remaining HUTCHMED position as of Q1 2022 after selling out during the quarter.
  • ProShare Advisors sold 8,122 HUTCHMED shares in Q1 2022, an estimated $285K.
  • ProShare Advisors first reported a position in HUTCHMED in Q4 2018 and held it in 11 quarters.
  • ProShare Advisors's HUTCHMED position peaked at $423K in Q3 2021.
  • 130 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2022.

Based on ProShare Advisors's 13F filing for Q1 2022, filed 10 May 2022.